Brief: Clearside Biomedical Got Letter From Nasdaq That Listing Of Co's Common Stock Was Not In Compliance With Nasdaq Listing Rule
Sept 29 (Reuters) - Clearside Biomedical Inc CLSD.O :
* CLEARSIDE BIOMEDICAL - ON SEPT 27, GOT LETTER FROM NASDAQ
THAT
LISTING OF CO'S COMMON STOCK WAS NOT IN COMPLIANCE WITH NASDAQ
LISTING RULE
Further company coverage: CLSD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearside Biomedical,
See all newsBrief: Clearside Biomedical Completes Financial Restructuring And Emerges From Chapter 11 With Steel Partners As Plan Sponsor
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials